Corange of Bermuda, parent company of the German firm Boehringer Mannheim, achieved net income in 1995 of $316.4 million, up 46.7%. Operational income was ahead 16.8% to $485 million. Sales for the year were $3.9 billion, up 14%.
The Boehringer Mannheim group produced 83% of Corange's 1995 revenues with $3.3 billion. The German firm's therapeutics division achieved turnover of $1.1 billion, the patient care division generated sales of $978 million, laboratory diagnostics sales were $1 billion, and the biochemicals division achieved turnover of $222 million. All divisions posted growth in 1995.
The DuPuy group, an orthopedics business, reported sales of $657 million, up 14%.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze